Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of life in men with LUTS/BPH according to routine treatment
ISRCTN11815680Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2009
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tamsulosin, finasteride, dutasteride, pygeum africanum extract and saw palmetto fruit extract in benign prostatic hyperplasia (BPH) (6 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Quality of life. Started Sep 2009; status: completed.
02
Drugs
tamsulosinfinasteridedutasteridepygeum africanum extractsaw palmetto fruit extract
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ISRCTN11815680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11815680.